Physician profile
Frida Isakov
NPI 1700301181
$1,140.28
in general payments reported to CMS, 2019-2025
21 companies · $21.66 in 2025
The $21.66 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $436 · 2023: $545 · 2024: $137 · 2025: $21.66.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $269.97 | 2023-2025 | |
| Antares Pharma, INC. | $137.99 | 2022-2023 | Xyosted, Nocdurna, Tlando |
| Glaxosmithkline, LLC. | $115.49 | 2022-2023 | Shingrix, Arexvy |
| Bayer Healthcare Pharmaceuticals INC. | $83.16 | 2022 | |
| Lilly USA, LLC | $81.13 | 2022-2024 | Zepbound, Jardiance, Mounjaro |
| Alkermes, INC. | $60.74 | 2022-2023 | Vivitrol |
| Medicomp INC | $56.20 | 2022 | |
| Abbott Laboratories | $48.99 | 2022-2023 | Freestyle Libre 3 |
| Halozyme INC | $42.45 | 2023 | |
| Intra-Sana Laboratories | $39.40 | 2023 | Reltone 400 Mg, Reltone 200 Mg, Glycate |
| Ardelyx, INC. | $23.51 | 2023 | Ibsrela |
| Verrica Pharmaceuticals INC. | $22.76 | 2024 | Ycanth |
| Pfizer INC. | $22.11 | 2024 | |
| Novo Nordisk INC | $20.92 | 2022 | |
| Exact Sciences Corporation | $19.86 | 2023 | Cologuard Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Renalytix Ai, INC. | $19.74 | 2023 | Kidneyintelx Blood Collection Convenience Kit |
| Hologic Sales and Service, LLC | $17.37 | 2022 | |
| Indivior INC. | $17.30 | 2023 | Sublocade |
| Corium, LLC | $14.60 | 2023 | Azstarys |
| Tolmar, INC. | $13.58 | 2024 | |
| Merck Sharp & Dohme LLC | $13.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frida Isakov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.